IL141586A0 - Cyclic prosaposin-derived peptide and uses thereof - Google Patents

Cyclic prosaposin-derived peptide and uses thereof

Info

Publication number
IL141586A0
IL141586A0 IL14158699A IL14158699A IL141586A0 IL 141586 A0 IL141586 A0 IL 141586A0 IL 14158699 A IL14158699 A IL 14158699A IL 14158699 A IL14158699 A IL 14158699A IL 141586 A0 IL141586 A0 IL 141586A0
Authority
IL
Israel
Prior art keywords
derived peptide
prosaposin
cyclic
cyclic prosaposin
peptide
Prior art date
Application number
IL14158699A
Other languages
English (en)
Original Assignee
Myelos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myelos Corp filed Critical Myelos Corp
Publication of IL141586A0 publication Critical patent/IL141586A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IL14158699A 1998-08-28 1999-08-20 Cyclic prosaposin-derived peptide and uses thereof IL141586A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9835998P 1998-08-28 1998-08-28
PCT/US1999/019378 WO2000012553A1 (en) 1998-08-28 1999-08-20 Cyclic prosaposin-derived peptides and uses thereof

Publications (1)

Publication Number Publication Date
IL141586A0 true IL141586A0 (en) 2002-03-10

Family

ID=22268937

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14158699A IL141586A0 (en) 1998-08-28 1999-08-20 Cyclic prosaposin-derived peptide and uses thereof

Country Status (13)

Country Link
EP (1) EP1105420A1 (hu)
JP (2) JP4528443B2 (hu)
KR (1) KR20010079695A (hu)
CN (1) CN1324367A (hu)
AU (1) AU751034B2 (hu)
BR (1) BR9913490A (hu)
CA (1) CA2341810A1 (hu)
CZ (1) CZ2001655A3 (hu)
HU (1) HUP0103265A3 (hu)
IL (1) IL141586A0 (hu)
PL (1) PL204359B1 (hu)
WO (1) WO2000012553A1 (hu)
ZA (1) ZA200102489B (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
CA2341810A1 (en) * 1998-08-28 2000-03-09 Myelos Corporation Cyclic prosaposin-derived peptides and uses thereof
AUPQ084899A0 (en) * 1999-06-08 1999-07-01 University Of Melbourne, The Neurotrophin agonists
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
CN100366286C (zh) * 2003-04-28 2008-02-06 常州南云科技有限公司 Saposin C-DOPS:一种抗癌新药
WO2007127439A2 (en) 2006-04-28 2007-11-08 Children's Hospital Medical Center Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems
CN101541307A (zh) * 2006-10-20 2009-09-23 儿童医院医疗中心 自发形成的椭圆体磷脂单层囊泡
CN103275187B (zh) * 2013-06-14 2014-10-29 四川合泰新光生物科技有限公司 一种镇痛肽fi及其基因和应用
EP3285735B1 (en) 2015-04-23 2021-06-23 The Procter & Gamble Company Delivery of surfactant soluble anti-dandruff agent
EP3423031B1 (en) 2016-03-03 2021-09-08 The Procter & Gamble Company Aerosol antidandruff composition
CN109843252A (zh) 2016-10-21 2019-06-04 宝洁公司 指定毛发体积有益效果的浓缩型洗发剂泡沫剂型
US10888505B2 (en) 2016-10-21 2021-01-12 The Procter And Gamble Company Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space
EP3528894A1 (en) 2016-10-21 2019-08-28 The Procter and Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
CN109862944A (zh) 2016-10-21 2019-06-07 宝洁公司 用于以最佳制剂空间递送消费者所需的剂型体积和表面活性剂量的泡沫剂型
EP3528898A1 (en) 2016-10-21 2019-08-28 The Procter and Gamble Company Concentrated shampoo dosage of foam designating hair conditioning benefits
CN109789076A (zh) 2016-10-21 2019-05-21 宝洁公司 具有低粘度和粘度降低剂的稳定致密洗发剂产品
CN109843381A (zh) 2016-10-21 2019-06-04 宝洁公司 用于提供毛发护理有益效果的浓缩型洗发剂泡沫剂型
US11224567B2 (en) 2017-06-06 2022-01-18 The Procter And Gamble Company Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel
US11679073B2 (en) 2017-06-06 2023-06-20 The Procter & Gamble Company Hair compositions providing improved in-use wet feel
US11141370B2 (en) 2017-06-06 2021-10-12 The Procter And Gamble Company Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel
CN111201010A (zh) 2017-10-10 2020-05-26 宝洁公司 用呈泡沫形式的个人护理组合物处理毛发或皮肤的方法
EP4400092A3 (en) 2017-10-10 2024-10-16 The Procter & Gamble Company Compact shampoo composition with amino acid based anionic surfactants and cationic polymers
US11116703B2 (en) 2017-10-10 2021-09-14 The Procter And Gamble Company Compact shampoo composition containing sulfate-free surfactants
JP2020536885A (ja) 2017-10-10 2020-12-17 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 無機塩低含有の、サルフェートを含まないパーソナルクレンジング組成物
MX2020005900A (es) 2017-12-20 2022-03-31 Procter & Gamble Composicion de champu clara que contiene polimeros de silicona.
US11318073B2 (en) 2018-06-29 2022-05-03 The Procter And Gamble Company Low surfactant aerosol antidandruff composition
WO2021113583A1 (en) 2019-12-06 2021-06-10 The Procter & Gamble Company Sulfate free composition with enhanced deposition of scalp active
WO2021173203A1 (en) 2020-02-27 2021-09-02 The Procter & Gamble Company Anti-dandruff compositions with sulfur having enhanced efficacy and aesthetics
CN116568263A (zh) 2020-12-04 2023-08-08 宝洁公司 包含恶臭减少材料的毛发护理组合物
US20220378684A1 (en) 2021-05-14 2022-12-01 The Procter & Gamble Company Shampoo Compositions Containing a Sulfate-Free Surfactant System and Sclerotium Gum Thickener
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
CA2341810A1 (en) * 1998-08-28 2000-03-09 Myelos Corporation Cyclic prosaposin-derived peptides and uses thereof

Also Published As

Publication number Publication date
CN1324367A (zh) 2001-11-28
HUP0103265A2 (hu) 2002-02-28
PL346346A1 (en) 2002-02-11
CA2341810A1 (en) 2000-03-09
HUP0103265A3 (en) 2002-09-30
JP2010150272A (ja) 2010-07-08
JP2002523518A (ja) 2002-07-30
EP1105420A1 (en) 2001-06-13
BR9913490A (pt) 2001-09-25
JP4528443B2 (ja) 2010-08-18
PL204359B1 (pl) 2010-01-29
AU751034B2 (en) 2002-08-08
CZ2001655A3 (cs) 2001-11-14
ZA200102489B (en) 2002-06-04
AU5690599A (en) 2000-03-21
WO2000012553A1 (en) 2000-03-09
KR20010079695A (ko) 2001-08-22

Similar Documents

Publication Publication Date Title
IL141586A0 (en) Cyclic prosaposin-derived peptide and uses thereof
PL348648A1 (en) Cyclic tetrapeptide compound and use thereof
EP1064022A4 (en) HLA BINDING PEPTIDES AND THEIR APPLICATIONS
HUP0102535A3 (en) Cd19xcd3 specific polypeptides and uses thereof
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
GB9806806D0 (en) Peptides and uses thereof
EP1056465A4 (en) ANTIMICROBIAL PEPTIDES AND DERIVATIVE METAPEPTIDES
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
IL125908A0 (en) Peptides and pharmaceutical compositions comprising same
HK1046925A1 (zh) Mage-a12抗原肽及其用途
EP0970965A4 (en) CYCLIC PEPTIDES AND MEDICAL USE THEREOF
GB9918155D0 (en) Proteins and peptides
IL125262A0 (en) Synthetic peptides and pharmaceutical compositions comprising them
GB9714276D0 (en) Peptides and related compounds
EP1080185A4 (en) BASIC PROTEIN PEPTIDES OF MYELIN AND THE USE THEREOF.
ZA9711392B (en) Cyclic peptide derivatives
GB9917165D0 (en) Polypeptides polynuclcotides and uses thereof
PL341293A1 (en) Beta-lypothropin and application thereof
SG74707A1 (en) Cyclic bis-phosphites and compositions
EP1132472A4 (en) NEW PROTEIN AND ITS APPLICATION
EP1067140A4 (en) NEW HEMOLYTICALLY ACTIVE PROTEINS AND GENES ENCODING THEM
EP1139972A4 (en) DIHYDROPYRIMIDINES AND THEIR USES
EP1066051A4 (en) SCIELLIN AND ITS USE
GB9815088D0 (en) Peptide and method
GB9827375D0 (en) Substance and uses thereof

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees